Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants.
Hinney A, Nguyen TT, Scherag A, Friedel S, Brönner G, Müller TD, Grallert H, Illig T, Wichmann HE, Rief W, Schäfer H, Hebebrand J. · 2007
Read Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. by Hinney A, Nguyen TT, Scherag A, Friedel S, Brönner G, Müller TD, Grallert H, Illig T, Wichmann HE, Rief W, Schäfer H, Hebebrand J. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2137937.txt.
Introduction
Hinney and co-workers ran a genome-wide association study in 2007 for extreme obesity starting early in life. Obesity is strongly inherited, yet the genes behind it were poorly known. The team scanned 440,794 single-letter DNA variants in 487 extremely obese young Germans and 442 lean controls. They then checked the strongest hits in 644 independent families with obese children.
Six variants in one gene, FTO, showed the strongest link to obesity. The top variant carried an odds ratio of 2.76, and its corrected significance passed the strict threshold. That odds value pointed to a real effect rather than chance variation in this sample. Both tested FTO variants were confirmed in the family study. Nine other promising variants failed to confirm. Only the FTO signals counted as true positives.
Catalog record
| CREATOR | Hinney A, Nguyen TT, Scherag A, Friedel S, Brönner G, Müller TD, Grallert H, Illig T, Wichmann HE, Rief W, Schäfer H, Hebebrand J. |
|---|---|
| YEAR | 2007 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 18 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Genome Wide Association (GWA) Study for Early Onset Extreme Obesity Supports the Role of Fat Mass and Obesity Associated Gene (FTO) Variants By Anke Hinney, Thuy Trang Nguyen, André Scherag, Susann Friedel, Günter Brönner, Timo Dirk Müller, Harald Grallert, Thomas Illig, H.-Erich Wichmann, Winfried Rief, Helmut Schäfer, Johannes Hebebrand Published in: PLoS ONE DOI: 10.1371/journal.pone.0001361 ABSTRACT Background Obesity is a major health problem. Although heritability is substantial, genetic mechanisms predisposing to obesity are not very well understood. We have performed a genome wide association study (GWA) for early onset (extreme) obesity. Methodology/Principal Findings a) GWA (Genome-Wide Human SNP Array 5.0 comprising 440,794 single nucleotide polymorphisms) for early onset extreme obesity based on 487 extremely obese young German individuals and 442 healthy lean German controls; b) confirmatory analyses on 644 independent families with at least one obese offspring and both parents. We aimed to identify and subsequently confirm the 15 SNPs (minor allele frequency ≥10%) with the lowest p-values of the GWA by four genetic models: additive, recessive, dominant and allelic. Six single nucleotide polymorphisms (SNPs) in FTO (fat mass and obesity associated gene) within one linkage disequilibrium (LD) block including the GWA SNP rendering the lowest p-value (rs1121980; log-additive model: nominal p = 1.13×10−7, corrected p = 0.0494; odds ratio (OR)CT 1.67, 95% confidence interval (CI) 1.22–2.27; ORTT 2.76, 95% CI 1.88–4.03) belonged to the 15 SNPs showing the strongest evidence for association with obesity. For confirmation we genotyped 11 of these in the 644 independent families (of the six FTO SNPs we chose only two representing the LD bock). For both FTO SNPs the initial association was confirmed (both Bonferroni corrected p<0.01). However, none of the nine non-FTO SNPs revealed significant transmission disequilibrium. Conclusions/Significance Our GWA for extreme early onset obesity substantiates that variation in FTO strongly contributes to early onset obesity. This is a further proof of concept for GWA to detect genes relevant for highly complex phenotypes. We concurrently show that nine additional SNPs with initially low p-values in the GWA were not confirmed in our family study, thus suggesting that of the best 15 SNPs in the GWA only the FTO SNPs represent true positive findings. INTRODUCTION The advent of genome wide association studies (GWAs) already has had a major impact on the identification of polygenes involved in human body weight regulation [1]. However, a GWA based on obese cases and lean controls has not yet been described. GWA have recently proven extremely powerful for the detection of genes/SNPs for different complex disorders [2], [3]. The progress has been particularly impressive for type 2 diabetes mellitus (T2DM) [4]–[7]. FTO was one of the genes picked up in GWA studies for T2DM [5], [6], adjustment for BMI revealed that this effect was solely based on this quantitative phenotype [5]. We performed a GWA (Genome-Wide Human SNP Array 5.0; Affymetrix) on patient samples stemming from both ends of the BMI distribution and subsequently aimed to confirm the 15 GWA SNPs with minor allele frequency (MAF) ≥10% rendering the lowest p-values determined upon analysis of four genetic models (additive, recessive, dominant and allelic) in an independent family-based study. RESULTS The GWA was analysed for the four genetic models additive, recessive, dominant and allelic. By sorting all analysed SNPs with a MAF ≥10% by minimal nominal p-values a list was derived for the best 15 SNPs (Table 1). Six SNPs (rs1121980, rs9939973, rs7193144, rs9940128, rs8050136, rs9939609, pair-wise r2 range 0.88–1) in FTO were among these 15 best SNPs of the scan (see Table 1); all six SNPs localize to the same linkage disequilibrium (LD) block. FTO-SNP rs1121980 rendered the lowest nominal p-value of 1.13×10−7; this SNP was the only SNP that survived correction for multiple testing (corrected p = 0.0494; Table 1). The log-additive OR for the rs1121980 risk T-allele was 1.66 (95% CI 1.37–2.01); the odds ratios for heterozygotes (CT) and homozygotes (TT) were estimated at 1.67 (95% CI 1.22–2.27) and 2.76 (95% CI 1.88–4.03), respectively. Frequencies of the T-allele in cases and controls were 0.53 and 0.41 (Table 1). [Table: Top 15 SNPs associated with early onset extreme obesity from the Genome-Wide Human SNP Array 5.0 (lowest nominal p-values across four genetic models) and their confirmation using family-based association studies for the risk allele derived from the GWA data] Eleven of the best 15 markers were subsequently genotyped in 644 independent obesity families based on at least one young obese index patient; of the six positive FTO SNPs belonging to the same LD block, we genotyped only the two SNPs with the lowest p-values. Confirmation of the initial finding using FBAT (family-based association test) was detected for the two FTO SNPs (both Bonferroni corrected p≤0.01). However, none of the risk alleles of the nine other SNPs showed evidence for association in the independent families. Additionally, similar to the approach of Scuteri et al. [8], we analysed specific candidate genes (coding sequence plus approximately 50 kb flanking the 5′ and 3′ regions, respectively). We chose those candidate genes delineated in the current version of the Obesity Gene Map Database (http://obesitygene.pbrc.edu/; [9]), for which two or more independent positive associations to obesity have been reported in addition to those genes listed in the Database to harbour mutations leading to monogenic forms of obesity. In Table S1 (Supporting Information), for each of these genes, the SNP with the lowest p-value and the respective genetic model are shown. Overall, among the 745 SNPs tested 75 (12) had a p-value below 0.05 (0.01). We re-assessed the original publications for the markers in Table S1 (Supporting Information) which had a nominal p-value below 0.005. For three SNPs of the previous publications (ESR1: rs2234693; rs9340799 and LDLR rs688) HapMap data were available. Hence, we checked for linkage disequilibrium by D' and r2. For ESR1 both previously investigated SNPs (rs2234693; rs9340799 [10], [11]) were approximately 16 kb apart from the 500k SNP rs712221. D' was 0.321 and 0.809, respectively, r2 was 0.103 and 0.378, respectively. For LDLR the previous SNP (rs688 [12], [13]) was just 48 bp apart from the 500k SNP rs1799898. D' was 1 and r2 was 0.144. However, the allele frequencies of the original SNPs and the closest GWA SNPs were quite different (e.g. rs1799898 MAF approximately 12% versus a MAF of 45% in rs688), complicating statements dealing with whether or not both markers tag the same disease related haplotype. Clearly, this possibility requires further attention. DISCUSSION Here we show by a GWA including early onset extremely obese cases (mean BMI Zscore 4.63±2.27) and healthy underweight controls (mean BMI Zscore −1.38±0.35; BMI<15th age percentile) that variation in FTO strongly contributes to the development of early onset obesity. Recently, the FTO gene was found to be associated with T2DM as based on two GWAs [5], [6]. However, after adjusting for BMI the T2DM association vanished indicating that FTO explains variation of body weight. Confirmation in 13 samples with 38,759 individuals and a meta-analysis showed that the A-allele of the variant rs9939609 is associated with a 31% increased risk to develop obesity [5]. These results were independently supported in 8,000 individuals from different populations [14] and in a GWA for obesity-related traits in an epidemiological cohort [8]. The best SNP rs1421085 of the study of